Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

Oncopeptides Appoints Joseph Horvat President North America (2019-12-02)
Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that Joseph Horvat has been appointed as President North America and CEO of Oncopetides Inc. Joseph will serve on the Management Team of Oncopeptides and will start today. The appointment of Joseph Horvat ...
Diabeloop Gets €31m Funding, incl. €22m Capital Increase (2019-12-02)
> Diabeloop announced today that it has completed a 31-million-euro Series B round of funding, setting a European fundraising record in the area of therapeutic artificial intelligence > This funding will allow Diabeloop to accelerate its international commercial...
Ligand & Sanofi: Global OmniAb Platform License Agreement (2019-12-02)
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces it has entered into a worldwide OmniAb license agreement with Sanofi. Under the agreement, Sanofi will be able to use Ligand’s full OmniAb antibody discovery platform which includes OmniRat®, OmniFlic®, O...
Pierre Fabre & Puma Biotech Expand License for Neratinib (2019-12-02)
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, and Pierre Fabre have agreed to extend the terms of the license agreement in which Puma granted Pierre Fabre exclusive rights to develop and commercialize NERLYNX® (neratinib) within Europe and p...
Astellas to Acquire Audentes Therapeutics for $3b in Cash (2019-12-02)
- Complementary capabilities and resources of the two organizations create an industry-leading gene therapy company - Audentes to operate as an independent subsidiary, with access to the global scientific and development resources of Astellas to accelerate produ...
Owkin Teams Up with Nvidia and King's College London (2019-12-02)
Owkin, which is developing Federated Learning and AI technologies to advance medical research, announces it is teaming up with technology company NVIDIA and King's College London (KCL) to deliver Federated Learning in the healthcare and life sciences sector. The Ki...
Sensorion: Phase 2b Trial of SENS-111 Misses Endpoint (2019-12-02)
> Safe and well tolerated in 105 AUV patient study; primary efficacy endpoint not met > No further activities related to SENS-111 will be pursued > Sensorion will now focus on advancing its hearing loss disorders pipeline Sensorion (Paris:ALSEN) (FR00125...
MedinCell Receives up to $19m Grant from Gates Foundation (2019-11-28)
The agreement with the Bill & Melinda Gates Foundation provides that MedinCell owns the marketing rights of the product worldwide, particularly in the United States. French company MedinCell and the Bill & Melinda Gates Foundation have signed an agreement fo...
MaxiVax: €2.8m EU Grant & CHF5m Series B2 Round (2019-11-26)
> MaxiVAX wins grant among 94 projects funded out of 2,015 applications > Closing of Series B 2 round of CHF 5 million from new and existing investors > Funds used for Phase 2 cancer programs MaxiVAX SA, a private Swiss clinical-stage biotech company ...
Sangamo Appoints James R. Meyers to Board of Directors (2019-11-26)
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the appointment of James R. Meyers, an accomplished pharmaceutical executive with three decades of commercial experience, to the Company's Board of Directors. "We are pleased ...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

Start here with the latest News!

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

» top